Cor Vasa 2026, 68(2):161-165 | DOI: 10.33678/cor.2025.100
Coronary Flow Velocity Reserve in Subjects with High HDL Cholesterol
- a Department of Endocrinology and Metabolism, Kocaeli City Hospital, Kocaeli, Turkey
- b Cardiology, Medeniyet University, Istanbul, Turkey
- c Department of Endocrinology and Metabolism, Medical Park Hospital, Istanbul, Turkey
Background: In recent years, it has been debated whether high HDL-C definitely provides cardiovascular protection. We compared coronary flow velocity reserve (CFVR) of subjects with normal HDL-C levels with subjects who have high HDL-C levels.
Methods and results: Subjects who were evaluated for angina with no pathological findings at the Cardiology Department of Istanbul Medeniyet University between 2012–2022 were screened and included to analysis if their HDL-C levels were ≥ 50 mg/dL. They were divided into two groups: (1) patients with HDL-C ≥ 70 mg/dL and (2) patients with HDL-C ≥ 50 and < 70 mg/ dL. Groups were compared in terms of CFVR.
Results: A total of 121 subjects (mean age: 37.60 ± 9.23; male n = 46, 38%) were included. There were 9 (7.4%) participants with HDL-C levels ≥ 70 mg/dL. When CFVR of participants with HDL-C ≥ 70 mg/dL was compared with participants with lower HDL (≥ 50 and < 70 mg/dL), CFVR was lower in the high HDL group (2.20 ± 0.52 vs. 2.65 ± 0.53, p = 0.007).
Conclusion: HDL-C levels ≥ 70 mg/dL may negatively impact coronary microcirculation.
Keywords: Coronary flow velocity reserve, Coronary microcirculation, High HDL-C
Received: July 11, 2025; Revised: July 11, 2025; Accepted: September 14, 2025; Prepublished online: June 2, 2012; Published: May 20, 2026 Show citation
References
- Despre J pierre. HDL-cholesterol as a marker of coronary heart disease risk : the Quebec cardiovascular study. Atherosclerosis 2000;153:263-272.
Go to original source...
Go to PubMed... - Wilson PWF, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham heart study. Arteriosclerosis 1988;8:737-741.
Go to original source...
Go to PubMed... - Tall AR, Rader DJ. Trials and Tribulations of CETP Inhibitors. Circ Res 2018;122:106-112.
Go to original source... - Gibson CM, Duffy D, Korjian S, et al. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction. N Engl J Med 2024;390:1560-1571.
Go to original source...
Go to PubMed... - Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality inmen and women: Two prospective cohort studies. Eur Heart J 2017;38:2478-2486.
Go to original source...
Go to PubMed... - Hirata A, Sugiyama D, Watanabe M, et al. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study. J Clin Lipidol 2018;12:674.e5-684.e5.
Go to original source...
Go to PubMed... - Takaeko Y, Matsui S, Kajikawa M, et al. Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men. J Clin Lipidol 2019;13:664.e1-672.e1.
Go to original source... - Liu C, Dhindsa D, Almuwaqqat Z, et al. Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality. Am J Cardiol. 2022;167:43-53.
Go to original source... - Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis 2019;290:140-205.
Go to original source...
Go to PubMed... - Erdogan D, Caliskan M, Gullu H, et al. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis 2007;191:168-174.
Go to original source... - Djordjevic Dikic A, Tesic M, Boskovic N, et al. Prognostic Value of Preserved Coronary Flow Velocity Reserve by Noninvasive Transthoracic Doppler Echocardiography in Patients With Angiographically Intermediate Left Main Stenosis. J Am Soc Echocardiogr 2019;32:74-80.
Go to original source... - Van De Hoef TP, Siebes M, Spaan JAE, Piek JJ. Fundamentals in clinical coronary physiology: why coronary flow is more important than coronary pressure. Eur Heart J 2015;36:3312-3319.
Go to original source...
Go to PubMed... - Erdogan D, Yildirim I, Ciftci O, Ozer I. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 2007;115:593-599.
Go to original source...
Go to PubMed... - Kaul S, Coin B, Hedayiti A, et al. Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex. J Am Coll Cardiol 2004;44:1311-1319.
Go to original source... - Tardif JC. Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology? J Clin Lipidol 2010;4:399-404.
Go to original source... - Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292-2300.
Go to original source... - Nicholls SJ, Puri R, Ballantyne CM, et al. Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial. JAMA Cardiol 2018;3:806-814.
Go to original source...
Go to PubMed... - Franczyk B, Rysz J, Ławiński J, Rysz-Górzyńska M, Gluba-Brzózka A. Is a high hdl-cholesterol level always beneficial? Biomedicines. 2021;9:1083.
Go to original source... - Barter PJ, Brewer HB, Chapman MJ, et al. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:160-167.
Go to original source...
Go to PubMed... - Schwartz GG, Olsson AG, Abt M, et al. Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome. N Engl J Med 2012;367:2089-2099.
Go to original source...
Go to PubMed... - Barter PJ, Caulfield M, Eriksson M, et al. Effects of Torcetrapib in Patients at High Risk for Coronary Events. N Engl J Med 2007;357:2109-2122.
Go to original source...
Go to PubMed... - Boden WE, Probst-field JL, Anderson T, Chaitman BR. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. N Engl J Med. 2011;365:2255-2267.
Go to original source... - Bowman L, Hopewell JC, Chen F, et al. The members of the writing committee. N Engl J Med. 2017;13:1217-1244.
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111-188.
Go to original source...
Go to PubMed... - Tsuda S, Shinohara M, Oshita T, et al. Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B 4 pathway by high-density lipoprotein in macrophages. Sci Rep. 2017;7:12989..
Go to original source... - Kontush A, Lindahl M, Lhomme M, et al. Structure of HDL: particle subclasses and molecular components. Handb Exp Pharmacol. 2015;224:3-51.
Go to original source... - Khera A V., Cuchel M, de la Llera-Moya M, et al. Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis. N Engl J Med 2011;364:127-135.
Go to original source... - Gomaraschi M, Ossoli A, Pozzi S, et al. eNOS activation by HDL is impaired in genetic CETP deficiency. PLoS One 2014;9:3-10.
Go to original source...
Go to PubMed... - Van Eck M, Twisk J, Hoekstra M, et al. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem 2003;278:23699-23705.
Go to original source...
Go to PubMed... - Zanoni P, Khetarpal SA, Larach DB, et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 2016;351:1166-1171.
Go to original source...
Go to PubMed... - Agerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene. Circulation 2000;101:1907-1912.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.




